APPN vs JAZZ · rev $405.4M vs P/E 1988, rev $2.28B
Appian Corp (APPN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Appian Corp (APPN) is a software - infrastructure company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported APPN revenue for 2026-06-30 was $405.4M. Net income was -$13.3M. APPN currently screens at market cap $2.26B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
APPN currently screens at market cap $2.26B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the APPN and JAZZ stock pages for the full models.
Not investment advice.